We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
-13.75%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$6.96M
Cap. Flow
+$37M
Cap. Flow %
15.03%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$37M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 98.45%
2 Miscellaneous 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$132M 53.58%
1,111,111
– –
BCRX icon
2
BioCryst Pharmaceuticals
BCRX
$2.52B
$62.5M 25.44%
3,846,154
– –
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$47.8M 19.42%
31,833,334
+22,666,667
+247% +$37M
EPZM
4
CALL
DELISTED
Epizyme, Inc
EPZM
$3.82M 1.55%
2,548,284
+2,150
+0.1% +$3.5K
VIRX
5
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$18K 0.01%
3,700
– –

Similar funds

PC
Paradoxiom Capital Stamford, Connecticut $154M AUM
LA
LPF Advisors Sarasota, Florida $122M AUM 3.12% 1-Year Est. Return
TP
Thunderbird Partners London, United Kingdom $113M AUM 8.51% 1-Year Est. Return
SC
Serenity Capital Palo Alto, California $167M AUM
MADFP
Michael A Dubis Financial Planning Middleton, Wisconsin $103M AUM
RM
RCF Management Denver, Colorado $103M AUM
NC
Napatree Capital Westerly, Rhode Island $178M AUM 8.09% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

RP Management's Q1 2022 Portfolio in Review

As of Q1 2022, RP Management held 5 positions worth $246M, up 2.9% from $239M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RP Management deployed $37M of net new capital in Q1 2022, adding to 2 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Miscellaneous.

  • RP Management added most to Epizyme, Inc in Q1 2022, an estimated $37M increase.
  • RP Management's ten largest holdings make up 100% of its $246M portfolio in Q1 2022.
  • RP Management opened 0 new positions and closed 0 in Q1 2022.
  • RP Management's portfolio value rose 2.9% quarter-over-quarter to $246M.

Based on RP Management's 13F filing for Q1 2022, filed 11 May 2022.